[go: up one dir, main page]

FR2892023B1 - Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale - Google Patents

Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale

Info

Publication number
FR2892023B1
FR2892023B1 FR0510504A FR0510504A FR2892023B1 FR 2892023 B1 FR2892023 B1 FR 2892023B1 FR 0510504 A FR0510504 A FR 0510504A FR 0510504 A FR0510504 A FR 0510504A FR 2892023 B1 FR2892023 B1 FR 2892023B1
Authority
FR
France
Prior art keywords
unigeal
ungueal
amorolfin
peri
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0510504A
Other languages
English (en)
Other versions
FR2892023A1 (fr
Inventor
Claire Mallard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0510504A priority Critical patent/FR2892023B1/fr
Application filed by Galderma SA filed Critical Galderma SA
Priority to PCT/FR2006/002307 priority patent/WO2007042682A1/fr
Priority to BRPI0617576-7A priority patent/BRPI0617576A2/pt
Priority to EP06820207A priority patent/EP1937228A1/fr
Priority to JP2008535064A priority patent/JP2009511553A/ja
Priority to CA002625804A priority patent/CA2625804A1/fr
Publication of FR2892023A1 publication Critical patent/FR2892023A1/fr
Priority to US12/081,207 priority patent/US20080260656A1/en
Application granted granted Critical
Publication of FR2892023B1 publication Critical patent/FR2892023B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR0510504A 2005-10-14 2005-10-14 Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale Expired - Fee Related FR2892023B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0510504A FR2892023B1 (fr) 2005-10-14 2005-10-14 Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
BRPI0617576-7A BRPI0617576A2 (pt) 2005-10-14 2006-10-13 composiÇço farmacÊutica para aplicaÇço ungueal e periungueal e uso de uma composiÇço
EP06820207A EP1937228A1 (fr) 2005-10-14 2006-10-13 Composition pharmaceitique a base d' un agent antimycotique morpholinique et d' un agent filmogene hydrosoluble pour application ungueale et peri-ungueale
JP2008535064A JP2009511553A (ja) 2005-10-14 2006-10-13 爪および爪周辺への塗布のためのアモロルフィンおよび水溶性皮膜形成剤に基づく医薬組成物
PCT/FR2006/002307 WO2007042682A1 (fr) 2005-10-14 2006-10-13 Composition pharmaceitique a base d' un agent antimycotique morpholinique et d' un agent filmogene hydrosoluble pour application ungueale et peri-ungueale
CA002625804A CA2625804A1 (fr) 2005-10-14 2006-10-13 Composition pharmaceutique a base d'un agent antimycotique morpholinique et d' un agent filmogene hydrosoluble pour application ungueale et peri-ungueale
US12/081,207 US20080260656A1 (en) 2005-10-14 2008-04-11 Ungual/periungual compositions comprising morpholine compounds and water-soluble film-forming agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0510504A FR2892023B1 (fr) 2005-10-14 2005-10-14 Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale

Publications (2)

Publication Number Publication Date
FR2892023A1 FR2892023A1 (fr) 2007-04-20
FR2892023B1 true FR2892023B1 (fr) 2009-09-25

Family

ID=36592882

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0510504A Expired - Fee Related FR2892023B1 (fr) 2005-10-14 2005-10-14 Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale

Country Status (7)

Country Link
US (1) US20080260656A1 (fr)
EP (1) EP1937228A1 (fr)
JP (1) JP2009511553A (fr)
BR (1) BRPI0617576A2 (fr)
CA (1) CA2625804A1 (fr)
FR (1) FR2892023B1 (fr)
WO (1) WO2007042682A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958638A1 (fr) 2007-02-14 2008-08-20 Polichem S.A. Utilisation de chitosanes pour augmenter la vitesse de pousse des ongles
US10201490B2 (en) 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
EP1958639A1 (fr) * 2007-02-14 2008-08-20 Polichem S.A. Utilisation de chitosanes dans le traitement de maladies inflammatoires des ongles
EP2167023A2 (fr) 2007-06-19 2010-03-31 Cognis IP Management GmbH Mélanges d'hydrocarbures et leur utilisation
EP2164453B1 (fr) * 2007-06-19 2018-07-18 Cognis IP Management GmbH Préparations cosmétiques contenant des hydrocarbures
CN101677922B (zh) * 2007-06-19 2014-03-26 考格尼斯知识产权管理有限责任公司 烃混合物及其用途
US8758730B2 (en) 2009-02-26 2014-06-24 B.R.A.I.N. Biotechnology Research And Information Network Ag Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
EP2416758B8 (fr) 2009-04-09 2017-10-18 Pola Pharma Inc. Composition pharmaceutique antimycotique
CN102387785B (zh) 2009-04-09 2017-08-25 宝丽制药股份有限公司 抗真菌药物组合物
EP2470178B1 (fr) 2009-08-25 2018-10-17 Pola Pharma Inc. Composition pharmaceutique antimycotique
US8450089B2 (en) * 2009-11-23 2013-05-28 New York University Compounds as L-cystine crystallization inhibitors and uses thereof
FR2954163B1 (fr) * 2009-12-18 2012-03-16 Galderma Pharma Sa Utilisation d'un tensioactif cationique, avantageu-sement amphotere, pour la preparation d'une composition antifongique applicable sur l'ongle
KR101656121B1 (ko) 2010-03-17 2016-09-08 노바리크 게엠베하 안압 증가를 치료하기 위한 약학 조성물
EP2444063A1 (fr) 2010-10-20 2012-04-25 Novaliq GmbH Compositions pharmaceutiques liquides pour l'administration de principes actifs
EP2462921A1 (fr) 2010-11-11 2012-06-13 Novaliq GmbH Compositions pharmaceutiques liquides pour le traitement d'une maladie de la chambre postérieure de l'oeil
PT2714010T (pt) 2011-05-25 2017-05-05 Novaliq Gmbh Composição farmacêutica tópica à base de alcanos semifluorados
EP2714008B1 (fr) * 2011-05-25 2016-12-14 Novaliq GmbH Composition pharmaceutique pour application sur les ongles
GB2496656B (en) * 2011-11-18 2015-12-09 Lrc Products Film-Forming Formulation
CA2775393C (fr) * 2012-05-02 2014-04-29 Samy Saad Formulations pharmaceutiques topiques non aqueuses
CN113679697A (zh) 2012-09-12 2021-11-23 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
CA2883003C (fr) 2012-09-12 2021-11-16 Novaliq Gmbh Compositions d'alcanes semifluores
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
DE202016008738U1 (de) 2015-09-30 2019-04-09 Novaliq Gmbh Semifluorierte Verbindungen und ihre Zusammensetzungen
DK3722274T3 (da) 2015-09-30 2023-09-11 Novaliq Gmbh 2-perfluorbutylpentan til oftalmisk indgivelse
ES2763121T3 (es) 2016-06-23 2020-05-27 Novaliq Gmbh Método de administración tópica
CA3036297C (fr) 2016-09-22 2023-09-05 Novaliq Gmbh Compositions pharmaceutiques destinees a etre utilisees dans la therapie de la blepharite
US10813976B2 (en) 2016-09-23 2020-10-27 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
ES2965883T3 (es) 2016-12-23 2024-04-17 Novaliq Gmbh Composición oftálmica para el tratamiento de la enfermedad del ojo seco
WO2018193093A1 (fr) 2017-04-21 2018-10-25 Novaliq Gmbh Compositions d'iode
US11278503B2 (en) 2017-05-12 2022-03-22 Novaliq Gmbh Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
CA3076776A1 (fr) 2017-09-27 2019-04-04 Novaliq Gmbh Compositions ophtalmiques comprenant du latanoprost, destinees a etre utilisees dans le traitement de maladies oculaires
CN120022260A (zh) 2017-10-04 2025-05-23 诺瓦利克有限责任公司 包含f6h8的眼用组合物
WO2019166631A1 (fr) 2018-03-02 2019-09-06 Novaliq Gmbh Compositions pharmaceutiques contenant du nébivolol
EP3784246A1 (fr) 2018-04-27 2021-03-03 Novaliq GmbH Compositions ophtalmiques comprenant du tafluprost pour le traitement du glaucome
JP7292567B2 (ja) 2018-09-27 2023-06-19 ダーマリック セラピューティクス， インコーポレーテッド 局所日焼け止め製剤
JP7360452B2 (ja) 2018-09-27 2023-10-12 ダーマリック セラピューティクス， インコーポレーテッド 脂質バリアの修復
AU2019358249B2 (en) 2018-10-12 2024-02-22 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
EP3923907B1 (fr) 2019-02-13 2024-09-25 Novaliq GmbH Compositions et procédés pour le traitement de la néovascularisation oculaire

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328319A (en) * 1980-10-27 1982-05-04 Restech Research Limited Partnership Process for preparing propellant compositions forming foamed structures containing open and/or closed cells
JPH01501143A (ja) * 1985-11-04 1989-04-20 ダ−マトロジカル・プロダクツ・オブ・テキサス 爪への薬物の施用のための皮膜形成性製剤用ヴェヒクル、これらのヴェヒクルを基にした薬剤組成物および同じものの使用法
AU3673195A (en) * 1994-10-13 1996-05-06 Hisamitsu Pharmaceutical Co., Inc. External preparation for nail ringworm
JP4253047B2 (ja) * 1996-09-27 2009-04-08 杏林製薬株式会社 被膜形成性抗真菌剤組成物
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
EP1263426B1 (fr) * 2000-01-03 2006-03-15 Karl Kraemer Preparations pour enlever de facon atraumatique des zones d'ongles
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
PL373235A1 (en) * 2002-09-05 2005-08-22 Galderma S.A. Solution for ungual application
WO2004084826A2 (fr) * 2003-03-21 2004-10-07 Nexmed Holdings, Inc. Enduit a ongles antifongique et procede d'utilisation
EP1648378A2 (fr) * 2003-07-29 2006-04-26 Pierre Fabre Dermo-Cosmetique Vernis a ongles a action antimycosique
FR2867978B1 (fr) * 2004-03-29 2009-02-20 Galderma Res & Dev Patch d'amorolfine pour le traitement de l'onychomicose

Also Published As

Publication number Publication date
WO2007042682A1 (fr) 2007-04-19
CA2625804A1 (fr) 2007-04-19
EP1937228A1 (fr) 2008-07-02
JP2009511553A (ja) 2009-03-19
US20080260656A1 (en) 2008-10-23
BRPI0617576A2 (pt) 2011-07-26
FR2892023A1 (fr) 2007-04-20

Similar Documents

Publication Publication Date Title
FR2892023B1 (fr) Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
DZ3491A1 (fr) Amines indanyle acyles et leurs utilisation comme agents pharmaceutiques
DK1411921T3 (da) Farmaceutiske sammensætninger indeholdende terbinafin og anvendelse deraf
EP1458362A4 (fr) Compositions pharmaceutiques sous forme particulaire
DE60316902D1 (de) Photopolymerisationsinitiator und photopolymerisierbare Zusammensetzung
FI20011478L (fi) Farmaseuttinen koostumus
IS2428B (is) Fljótandi lyfjasamsetning
HUP0500610A3 (en) Indazoles, benzothiazoles, and benzoisothiazoles, pharmaceutical compositions comprises thereof and their uses
FI20105657L (fi) Farmaseuttisia koostumuksia
MA26937A1 (fr) Nouvelle composition pharmaceutique.
ATE380544T1 (de) Umhüllte feste darreichungsform
EP1427407A4 (fr) Conjugues a base d'amines gras et d'agents pharmaceutiques
IL197159A0 (en) Rna molecules and pharmaceutical compositions containing the same
DK1524266T3 (da) Farmaceutisk sammensætning
EP1496913A4 (fr) Compositions pharmaceutiques neuroprotectrices a base de spirostenol
NO20033042D0 (no) Cyklodekstrin-inneholdende farmasöytisk preparat
IS7051A (is) Lyfjasamsetningar
DE60112983D1 (de) Überzugsmittel und gehärtetes Produkt
MA28844B1 (fr) Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol
FI20022128A7 (fi) Farmaseuttinen koostumus
EP1819323A4 (fr) Composition pharmaceutique renfermant un agent d'anti-nucleation
EP1814977A4 (fr) Compositions a base d'arthrospira et utilisations de celles-ci
FR2802423B1 (fr) Compositions pharmaceutiques
FR2833842B1 (fr) Compositions pharmaceutiques a base de derives d'azetidine
FR2872044B1 (fr) Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20170630